UBS maintains Willis Towers Watson at Buy, lowers price target to $395 from $398
UBS kept its Buy rating on Willis Towers Watson but reduced its price target to $395 from $398, representing a 0.8% decrease. The new target suggests a 21.3% upside from the stock's recent close of $325.51. Recent analyst price targets for the company range from $310 to $371.
How this was made

The 30-second read
Why it matters
The target reduction may trigger short-term selling but is unlikely to cause a major trend shift.
Market read
A small analyst target adjustment with limited trading impact.
What to watch
Recent contract wins and stable earnings could offset the analyst's slight downgrade.
Background
UBS maintains a Buy rating but adjusts its price target slightly lower, reflecting a modest reassessment of valuation.
Ticker impact
UBS lowered its price target on Willis Towers Watson to $395, a new analyst action.
likely pressure as the market prices in the reduced target
Analyst target cuts often lead to short-term sell pressure, especially when the change is modest.
Market effects
Minimal impact on the broader professional services sector.
Limited to U.S. markets where WTW trades.
Low global relevance.
Counterpoint
The target cut may be overly cautious; the stock could hold steady if fundamentals remain strong.
Key entities
- CompanyWillis Towers Watson
Global advisory, brokering and solutions company.
- Financial InstitutionUBS
Investment bank providing research and ratings.
